🇺🇸 FDA
Patent

US 9765063

Amido compounds as RORγt modulators and uses thereof

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 9765063 (Amido compounds as RORγt modulators and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/40, A61K31/4025, A61K31/445, A61K31/4709